261 related articles for article (PubMed ID: 15853611)
1. Mitoxantrone (Novantrone) in multiple sclerosis: new insights.
Neuhaus O; Kieseier BC; Hartung HP
Expert Rev Neurother; 2004 Jan; 4(1):17-26. PubMed ID: 15853611
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic role of mitoxantrone in multiple sclerosis.
Neuhaus O; Kieseier BC; Hartung HP
Pharmacol Ther; 2006 Jan; 109(1-2):198-209. PubMed ID: 16095713
[TBL] [Abstract][Full Text] [Related]
3. [Mitoxantrone for the treatment of patients with multiple sclerosis].
Komori M; Kondo T; Tanaka M
Brain Nerve; 2009 May; 61(5):575-80. PubMed ID: 19514518
[TBL] [Abstract][Full Text] [Related]
4. Tolerability and acceptance of prolonged low/delayed mitoxantrone regimens in patients with worsening multiple sclerosis.
Zecca C; Petrini L; Limoni C; Staedler C; Gobbi C
Eur Neurol; 2011; 65(1):40-5. PubMed ID: 21196739
[TBL] [Abstract][Full Text] [Related]
5. Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ
Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of mitoxantrone in multiple sclerosis--what is known?
Neuhaus O; Kieseier BC; Hartung HP
J Neurol Sci; 2004 Aug; 223(1):25-7. PubMed ID: 15261556
[TBL] [Abstract][Full Text] [Related]
7. Rationale for the use of mitoxantrone in multiple sclerosis.
Edan G; Morrissey S; Le Page E
J Neurol Sci; 2004 Aug; 223(1):35-9. PubMed ID: 15261558
[TBL] [Abstract][Full Text] [Related]
8. The argument against the use of cyclophosphamide and mitoxantrone in the treatment of multiple sclerosis.
Jeffery DR
J Neurol Sci; 2004 Aug; 223(1):41-6. PubMed ID: 15261559
[TBL] [Abstract][Full Text] [Related]
9. [Mitoxantrone].
Pericot I; Montalban X
Neurologia; 2003; 18(6):318-23. PubMed ID: 12838451
[TBL] [Abstract][Full Text] [Related]
10. Current disease-modifying treatment of multiple sclerosis.
Derwenskus J
Mt Sinai J Med; 2011; 78(2):161-75. PubMed ID: 21425262
[TBL] [Abstract][Full Text] [Related]
11. [Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis].
Feuillet L; Guedj E; Eusebio A; Malikova I; Pelletier J; Mundler O; Ali Chérif A;
Rev Neurol (Paris); 2003 Dec; 159(12):1169-72. PubMed ID: 14978418
[TBL] [Abstract][Full Text] [Related]
12. [Mitoxanthrone in the therapy of multiple sclerosis].
Kieseier BC; Gold R; Hartung HP
Nervenarzt; 2003 Oct; 74(10):906-10. PubMed ID: 14551698
[TBL] [Abstract][Full Text] [Related]
13. [Newer disease--modifying drugs: glatiramer acetate and mitoxantrone].
Kohriyama T; Higaki M; Matsumoto M
Nihon Rinsho; 2003 Aug; 61(8):1381-7. PubMed ID: 12962027
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent melanonychia by mitoxantrone.
Reinsberger C; Meuth SG; Wiendl H
Mult Scler; 2009 Sep; 15(9):1131-2. PubMed ID: 19570819
[TBL] [Abstract][Full Text] [Related]
15. Effect of mitoxantrone on MRI in progressive MS: results of the MIMS trial.
Krapf H; Morrissey SP; Zenker O; Zwingers T; Gonsette R; Hartung HP;
Neurology; 2005 Sep; 65(5):690-5. PubMed ID: 16157900
[TBL] [Abstract][Full Text] [Related]
16. Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis.
Cursiefen S; Flachenecker P; Toyka KV; Rieckmann P
Eur Neurol; 2000; 43(3):186-7. PubMed ID: 10765063
[No Abstract] [Full Text] [Related]
17. Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
Zipoli V; Portaccio E; Hakiki B; Siracusa G; Sorbi S; Amato MP
J Neurol Sci; 2008 Mar; 266(1-2):25-30. PubMed ID: 17870094
[TBL] [Abstract][Full Text] [Related]
18. Laquinimod, a new oral autoimmune modulator for the treatment of relapsing-remitting multiple sclerosis.
Tselis A
Curr Opin Investig Drugs; 2010 May; 11(5):577-85. PubMed ID: 20419604
[TBL] [Abstract][Full Text] [Related]
19. The current role of mitoxantrone in the treatment of multiple sclerosis.
Cocco E; Marrosu MG
Expert Rev Neurother; 2014 Jun; 14(6):607-16. PubMed ID: 24834466
[TBL] [Abstract][Full Text] [Related]
20. Mitoxantrone for multiple sclerosis in clinical practice.
Rizvi SA; Zwibel H; Fox EJ
Neurology; 2004 Dec; 63(12 Suppl 6):S25-7. PubMed ID: 15623666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
